Loading clinical trials...

Diabetes, Insulin Resistance and Body Composition | Clinical Trials | Clareo Health

COMPLETED

Diabetes, Insulin Resistance and Body Composition

The Correlation Between Diabetes, Insulin Resistance and Body Composition

NCT06724068•Xuan Song

Summary

The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions. The main question\[s\] it aims to answer are: * \[The difference of body composition between the individuals of insulin resistance and diabetes\] * \[The effect of diabetes on body composition\]

Eligibility

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Adults aged 18 years and older.
•2. Diagnosed with type 2 diabetes mellitus according to recognized diagnostic criteria.
•3. Availability of complete body composition data (e.g., DXA measurements).
•4. Documented HbA1c levels and other glycemic control data.
•5. Continuous medical records available during the study period

Exclusion Criteria

•1. Presence of other severe metabolic diseases, such as liver failure or kidney failure.
•2. Use of medications affecting muscle mass (e.g., glucocorticoids) for more than three months.
•3. History of malignancy or ongoing treatment for cancer.
•4. Missing critical research data (e.g., diabetes duration or HbA1c levels).
•5. History of surgeries causing significant body composition changes (e.g., bariatric surgery).

Locations (1)

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, China

Key Dates

Start Date

December 17, 2021

Primary Completion Date

August 31, 2022

Completion Date

August 31, 2022

Last Updated

December 12, 2024

Enrollment

515

ACTUAL participants

Conditions

Insulin Resistance, Diabetes

Interventions

Diabetes，Insulin resistance，Control

OTHER

Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise

NCT02977442

Insulin Resistance, Diabetes

View study

COMPLETEDNA

Duality of Lipids: the Athlete's Paradox

NCT03314714

Insulin Resistance, DiabetesLipid Metabolism Disorders

View study

COMPLETED

Validation of a Novel Screening Test for Maternal Insulin Resistance

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions